NASDAQ:ATRA
Atara Biotherapeutics Stock News
$0.692
-0.0232 (-3.25%)
At Close: Apr 18, 2024
Les bénéfices d'AG Barr au H1 glissent en raison des restrictions liées au COVID-19 | Invezz
09:26pm, Tuesday, 22'nd Sep 2020
AG Barr a enregistré une charge exceptionnelle de 11,5 millions £ au S1 et a dit que les paiements de dividendes pourraient être rétablis en 2021.
De H1 winst van AG Barr daalt vanwege COVID-19 beperkingen | Invezz
06:03pm, Tuesday, 22'nd Sep 2020
De winst van AG Barr over het eerste halfjaar daalt als gevolg van COVID-19. Het bedrijf zag in H1 £11,5 miljoen aan uitzonderlijke lasten.
Las ganancias de A.G. Barr se caen debido a las restricciones de COVID-19 en el primer semestre fiscal | Invezz
03:29pm, Tuesday, 22'nd Sep 2020
En un anuncio el martes, AG Barr plc (LON: BAG) dijo que su ganancia antes de impuestos en el primer semestre fiscal fue menor en una base anual. La compañía atribuyó la disminución a la pandemia
Il profitto di AG Barr diminuisce a causa del COVID-19 nel Q1 | Invezz
11:54am, Tuesday, 22'nd Sep 2020
La società ha registrato £11,5 milioni di spese eccezionali nel Q1. AG Barr afferma che i pagamenti dei dividendi potrebbero essere ripristinati nel 2021.
Week 38 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
04:30am, Tuesday, 15'th Sep 2020
Two sample breakout stocks for Week 38 with better than 10% short-term upside potential. Now up an average +199.7% YTD.
Wall Street Breakfast: The Week Ahead
04:42am, Sunday, 06'th Sep 2020
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
08:21am, Saturday, 05'th Sep 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Tracking Seth Klarman's Baupost Group Holdings - Q2 2020 Update
08:00am, Saturday, 15'th Aug 2020
Seth Klarman’s 13F portfolio value increased from $6.77B to $8.01B this quarter. Baupost Group increased Atara Biotherapeutics while dropping Cheniere Energy.
Genomic Medicine: Summer 2020 Update
09:36am, Thursday, 13'th Aug 2020
FDA approvals, new guidance statements, and RMAT requests all show the pace of genomics is accelerating.
Did Hedge Funds Make The Right Call On Atara Biotherapeutics Inc (ATRA) ?
01:53pm, Wednesday, 12'th Aug 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Cowen & Co. Remains a Buy on Atara Biotherapeutics (ATRA) - Markets
04:03pm, Sunday, 09'th Aug 2020
In a report issued on August 6, Phil Nadeau from Cowen & Co. maintained a Buy rating on Atara Biotherapeutics
H.C. Wainwright Keeps a Buy Rating on Atara Biotherapeutics (ATRA) - Markets
10:38am, Thursday, 06'th Aug 2020
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Atara Biotherapeutics (ATRA – Research
Canaccord Genuity Sticks to Its Buy Rating for Atara Biotherapeutics (ATRA) - Markets
10:35am, Thursday, 06'th Aug 2020
In a report released today, John Newman from Canaccord Genuity maintained a Buy rating on Atara Biotherapeutics (ATRA – Research
Atara Biotherapeutics Announces Second Quarter 2020 Financial Results and Operational Progress
08:01pm, Wednesday, 05'th Aug 2020
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases
Why Atara Biotherapeutics (ATRA) Might Surprise This Earnings Season
12:19pm, Tuesday, 04'th Aug 2020
Atara Biotherapeutics (ATRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
